Background: Previously it was shown that a new immunostimulator, peptidoglycan monomer linked with zinc (PGM-Zn), might have immunocorrective and hepatotropic effects. Owing to this in the present study we investigated its effects on jaundice-induced immunodysfunction, which might be responsible for serious peri- and postoperative complications in biliary obstruction. Methods: In vivo effects of PGM-Zn were analyzed in mice subjected to common bile duct ligation (CBDL), where we estimated phenotypic profile and cell cycle of thymocytes, splenocytes and phagocytic function of peritoneal macrophages. In vitro effects of PGM-Zn were evaluated on blastogenesis of human peripheral blood mononuclear cells (PBMNC), obtained from healthy donors and stimulated with anti-CD3 monoclonal antibody and/or PMA, in the presence or absence of jaundice serum obtained from patients with biliary calculosis. Results and Discussion: Jaundice induced marked disarrangement of lymphatic homeostasis, which at several points might be blocked by PGM-Zn. In mice it delayed the CBDL-induced decline of CD4+ CD8+ thymocytes, decreased the proportion of CD8+ T cells, and increased the percentage of CD4– CD8– thymocytes, augmenting simultaneously the proportion of thymic cells in S and G2 + M phase of cycle. Similar hyperplastic reaction with increased percentage of CD4+, Ig+ and CD5+ cells was noticed in the spleen, together with the enhanced phagocytic ability of peritoneal macrophages. In human PBMNC jaundice reduced the percentages of CD3, CD5, CD4, CD8 and HLA-DR-expressing cells and increased the proportion of CD25 and perforin-positive lymphocytes. PGM-Zn given in vitro was able to abrogate the antiproliferative activity of jaundice serum on PMA and anti-CD3 + PMA-induced blastogenesis.

Heumann D, Glauser MP, Calandra T: Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol 1998;1:49–55.
Weidemann B, Schletter J, Dziarski R, Kusumoto S, Stelter F, Rietschel ET, Flad HD, Ulmer AJ: Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun 1997;65:858–864.
Ellouz F, Adam A, Ciorbaru R, Lederer E: Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivates. Biochem Biophys Res Commun 1974;59:1317–1325.
Keglević D, Ladešić B, Tomašić J, Valinger Z, Naumski R: Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant. Biochim Biophys Acta 1979;585:273–281.
Tomašić J, Hršak I: Peptidoglycan monomer originating from Brevibacterium divaricatum – Its metabolism and biological activities in the host; in Schrinner E, Richmond MH, Seibert G, Schwarz U (eds): Surface Structures of Microorganismus and Their Interactions with the Mammalian Host. Proceedings of the 18th Workshop Conference Hoechst, Schloss Ringberg, 1987, pp 20–23.
Gabrilovac J, Tomašić J, Boranić M, Martin-Kleiner I, Osmak M: In vivo and in vitro modulation of NK and ADCC activities of mouse spleen cells by peptidoglycan monomer (PGM). Res Exp Med (Berl) 1989;189:265–273.
Radošević-Stašić B, Trobonjača Z, Petković M, Milin Č, Ćuk M, Muhvić D, Ravlić-Gulan J, Marić I, Rukavina D: Immunoregulating effects of peptidoglycan monomer linked with zinc in adult mice. Int Arch Allergy Immunol 1995;106:219–228.
Radošević-Stašić B, Ravlić-Gulan J, Trobonjača Z, Ćuk M, Muhvić D, Milin C, Rukavina D: Age-dependent effects of peptidoglycan monomer linked with zinc on the generation of suppressor macrophages in mice. Croat Med J 1997;38:212–216.
Ravlić-Gulan J, Radošević-Stašić B, Trobonjacă Z, Petković M, Ćuk M, Rukavina D: On the role of T lymphocytes in stimulation of humoral immunity induced by peptidoglycan-monomer linked with zinc. Int Arch Allergy Immunol 1999;119:13–22.
Holman JM, Rikkers LF: Biliary obstruction and host defense failure. J Surg Res 1982;32:208–213.
Jiang WG, Puntis MC: Immune dysfunction in patients with obstructive jaundice, mediators and implications for treatments. HPB Surg 1997;10:129–142.
Hameed A, Olsen KJ, Cheng I, Fox WM 3rd, Hruban RH, Podack ER: Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am J Pathol 1992;140:1025–1030.
Rakočević S, Silobrčić V: A peptidoglycan monomer as an antitumor agent in mice: Stimulation of phagocytosis by resident peritoneal macrophages with peptidoglycan monomer. J Biol Response Mod 1988;7:6–10.
Page DM, Kane LP, Allison JP, Hedrick SM: Two signals are required for negative selection of CD4+CD8+ thymocytes. J Immunol 1993;151:1868.
Prasad AS: Zinc and immunity. Mol Cell Biochem 1998;188:63–69.
Reinhold D, Ansorge S, Grungreiff K: Immunobiology of zinc and zinc therapy. Immunol Today 1999;20:102–103.
Sheen-Chen SM, Chau P, Harris HW: Obstructive jaundice alters Kupffer cell function independent of bacterial translocation. J Surg Res 1998;80:205–209.
Thompson RL, Hoper M, Diamond T, Rowlands BJ: Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice. Br J Surg 1990;77:1229–1232.
Aouad K, Calmus Y, Nordlinger B, Myara A, Weill B, Poupon R: Immunosuppressive effects of endotoxins and bile acids in vivo in the rat. Eur J Clin Invest 1996;26:45–48.
Clements WD, Erwin P, McCaigue MD, Halliday I, Barclay GR, Rowlands BJ: Conclusive evidence of endotoxemia in biliary obstruction. Gut 1998;42:293–299.
Henderson B, Poole S, Wilson M: Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996;60:316–341.
Tracy TF Jr, Dillon P, Fox ES, Minnick K, Vogler C: The inflammatory response in pediatric biliary disease: Macrophage phenotype and distribution. J Pediatr Surg 1996;31:121–125.
Fearns C, Loskutoff DJ: Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide. Infect Immun 1997;65:4822–4831.
Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ: CD14 is a pattern recognition receptor. Immunity 1994;1:509–516.
Dziarski R, Tapping RI, Tobias PS: Binding of bacterial peptidoglycan to CD14. J Biol Chem 1998;273:8680–8690.
Gupta D, Kirkland TN, Viriyakosol S, Dziarski R: CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem 1996;271:23310–23316.
Trešcec A, Iskrić S, Ljevaković D, Hršak I, Tomašić J: The effects of immunomodulating peptidoglycan monomer and muramyl dipeptide on hepatic microsomal UDP-glucuronyltransferase and beta-glucuronidase. Int J Immunopharmacol 1987;9:371–378.
Sprietsma JE: Modern diets and diseases: NO-zinc balance. Under Th1, zinc and nitrogen monoxide (NO) collectively protect against viruses, AIDS, autoimmunity, diabetes, allergies, asthma, infectious diseases, atherosclerosis and cancer. Med Hypotheses 1999;53:6–16.
Denham S, Rowland IJ: Inhibition of the reactive proliferation of lymphocytes by activated macrophages: The role of nitric oxide. Clin Exp Immunol 1992;87:157–162.
Kotb M: Superantigens of gram-positive bacteria: Structure-function analyses and their implications for biological activity. Curr Opin Microbiol 1998;1:56–65.
Roussel A, Anderson BF, Baker HM, Fraser JD, Baker EN: Crystal structure of the streptococcal superantigen SPE-C: Dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nat Struct Biol 1997;4:635–643.
Sundstrom M, Abrahmsen L, Antonsson P, Mehindate K, Mourad W, Dohlsten M: The crystal structure of staphylococcal enterotoxin type D reveals Zn2+-mediated homodimerization. EMBO J 1996;15:6832–6840.
Shankar AH, Prasad AS: Zinc and immune function: The biological basis of altered resistance to infection. Am J Clin Nutr 1998;68:447S–463S.
Wellinghausen N, Rink L: The significance of zinc for leukocyte biology. J Leukoc Biol 1998;64:571–577.
Dardenne M, Boukaiba N, Gagnerault MC, Homo-Delarche F, Chappuis P, Lemonnier D, Savino W: Restoration of the thymus in aging mice by in vivo zinc supplementation. Clin Immunol Immunopathol 1993;66:127–135.
Mocchegiani E, Perissin L, Santarelli L, Tibaldi A, Zorzet S, Rapozzi V, Giacconi R, Bulian D, Giraldi T: Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2. Int J Immunopharmacol 1999;21:27–46.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.